Menu

About the Journal

Aims and scope

Infectious Diseases and Therapy is an international, open access, peer-reviewed, rapid publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of infectious disease therapies and interventions, including vaccines and devices. Studies relating to diagnostic products and diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to, bacterial and fungal infections, viral infections (including HIV/AIDS and hepatitis), parasitological diseases, tuberculosis and other mycobacterial diseases, vaccinations and other interventions, and drug-resistance, chronic infections, epidemiology and tropical, emergent, pediatric, dermal and sexually-transmitted diseases.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, and short communications. The journal appeals to a global audience and receives submissions from all over the world.

Moving forward from traditional publishing, Infectious Diseases and Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include slide sets, videos and animations. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.

Infectious Diseases and Therapy publishes supplements and special issues (in English or a local language). Material appropriate for supplements/special issues include: sponsored meeting proceedings, roundtable discussions, workshop reports, case series, and collections of articles on the same topic. All articles are subject to peer review, and must adhere to the ICMJE and GPP policies on acknowledgments/disclosures. Proposals for supplements are welcomed, and should be addressed to victoria.john@springer.com.

Infectious Diseases and Therapy's rapid publication, personalized service, and open access is funded by article processing charges. Current fees are: £250/ €340/ $380 per typeset page. Please note, all manuscripts are thoroughly peer reviewed and accepted/rejected based purely on the merit of the content.

If you have any queries or would like any further information about the journal, please contact hannah.payne@springer.com.

Indexing: EMBASE, Google Scholar, OCLC, PubMed, PubMed Central, Summon by ProQuest

Published: 4 issues per year. Online. Articles are published online first with the DOI number, immediately after author approval. Paginated issues are collated four times per year (March, June, September and December).

eISSN: 2193-6382

Back to top